Chronic NAD Shortage Caused Frailty and Early Death in Mice; Niacin Reversed It

This is animal research, not a human trial. The paper describes experiments in mice.

NAD is a helper molecule that cells use in energy metabolism, DNA repair, gene regulation and signaling. Levels of NAD fall with vitamin B3 (niacin) deficiency, with disease and with aging. What has been unclear, the authors write, is what chronic NAD depletion does to the whole body.

The team used mice called ANDY, short for acquired niacin dependency. In these animals NAD synthesis becomes dependent on dietary niacin. On a niacin-free diet, NAD fell in tissues across the body. According to the paper's introduction, which we read on the journal page, ordinary rodents are hard to deplete this way because they convert tryptophan to NAD efficiently and so depend less on dietary niacin than people do, and the ANDY mice are transgenic.

The depleted mice showed a broad set of problems, as the study lists them: kyphosis (a curved spine), lower bone, lean and fat mass, poorer exercise capacity, browning of fur, frailty, cataracts, disrupted energy balance and a shorter lifespan. The effects appeared in both sexes. NAD loss also came with tissue inflammation and cellular senescence, a state in which cells stop dividing and can promote inflammation.

The link to normal aging is only partial. The study reports that gene activity in the NAD-depleted mice overlapped with chronological aging only in part. Some features resemble aging, but the match at the molecular level is limited. The paper's own introduction goes further and says the ANDY mouse should be viewed not as an aging model but as a model of chronic NAD deficiency. The introduction also describes the work as done in young mice.

Two treatments were tested. Senolytic treatment, which targets senescent cells, partly improved functional decline but did not restore NAD. Dietary niacin repletion reversed the physical, biochemical, senescence-related and gene-activity abnormalities. The authors conclude that recovering tissue NAD levels restored systemic function.

What does this mean for supplements? Less than headlines may suggest. The study tested a niacin-free diet followed by niacin repletion in mice engineered to depend on dietary niacin. It did not test NAD booster supplements, and it did not test whether raising NAD above normal levels helps healthy animals or people. The result supports the idea that a true NAD shortage is harmful and that supplying niacin can fix it in this model. It does not show that extra NAD boosters slow aging in people.

The comparison with getting enough niacin is therefore narrow. In this model, restoring the basic dietary supply of niacin was enough to reverse the deficiencydriven changes. Whether findings in mice with an engineered dependency carry over to people is an open question, and this is where the argument is weakest.

What to watch next

Whether other groups reproduce these results, and whether human studies can show if low NAD drives tissue decline in older people or only appears alongside it.